Water Extract of Angelica dahurica Inhibits Osteoclast Differentiation and Bone Loss

Int J Mol Sci. 2023 Sep 28;24(19):14715. doi: 10.3390/ijms241914715.


Angelica dahurica radix has a long history of traditional use in China and Korea for treating headaches, cold-damp pain and skin diseases. Despite various pharmacological studies on A. dahurica, its impact on bones remains unclear. Hence, this study investigated the inhibitory effect of A. dahurica's radix water extract (WEAD) on osteoclast differentiation. In vitro experiments showed that WEAD effectively suppresses osteoclast differentiation. Treatment of an osteoclast precursor with WEAD significantly suppressed the expression of nuclear factor of activated T-cells 1 (NFATc1), essential transcription factor for osteoclastogenesis, while increasing the expression of negative regulators, interferon regulatory factor 8 (Irf8) and v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (MafB). Consistent with the in vitro findings, the oral administration of WEAD (100 and 300 mg/kg/day) to mice subjected to surgical ovariectomy for a duration of six weeks alleviated bone loss, while also mitigating weight gain and liver fat accumulation. In addition, we also identified phytochemicals present in WEAD, known to regulate osteoclastogenesis and/or bone loss. These results suggest the potential use of WEAD for treating various bone disorders caused by excessive bone resorption.

Keywords: Angelica dahurica; osteoclast; osteoporosis; ovariectomy.

MeSH terms

  • Angelica* / metabolism
  • Animals
  • Bone Diseases, Metabolic* / metabolism
  • Bone Resorption* / drug therapy
  • Bone Resorption* / metabolism
  • Cell Differentiation
  • Female
  • Humans
  • Mice
  • NFATC Transcription Factors / metabolism
  • Osteoclasts / metabolism
  • Osteogenesis
  • Ovariectomy
  • RANK Ligand / metabolism


  • NFATC Transcription Factors
  • RANK Ligand